177Lu-FC516

Lutetium-177 labeled FC516 radiopharmaceutical · FindCure Biosciences (ZhongShan) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-FC516, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer [EARLY_Phase 1]